Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure.

COPD Cardio-oncology Chronic heart failure Chronic kidney disease Coronary artery disease Diabetes Hypertension Sleep apnea

Journal

European journal of internal medicine
ISSN: 1879-0828
Titre abrégé: Eur J Intern Med
Pays: Netherlands
ID NLM: 9003220

Informations de publication

Date de publication:
01 2020
Historique:
received: 23 03 2019
revised: 27 07 2019
accepted: 05 10 2019
pubmed: 12 11 2019
medline: 16 2 2021
entrez: 12 11 2019
Statut: ppublish

Résumé

The increasing number of patients with heart failure HF and comorbidities is due to aging population and increase of life expectancy of patients with cardiovascular disease. Encouraging results derived by recent trials may suggest some comorbidities as new targets for new drugs, highlighting the need for a better understanding of the comorbidities' effects in HF patients and the need of a multidisciplinary approach for the management of chronic HF with comorbidities. We report a brief review about main cardiovascular and non-cardiovascular comorbidities in HF patients in order to update physicians and researchers engaged in the HF research or in "fight against heart failure."

Identifiants

pubmed: 31708358
pii: S0953-6205(19)30342-5
doi: 10.1016/j.ejim.2019.10.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-31

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no financial or other interest in the product or distributor of the product. Furthermore, they have no other kinds of associations, such as consultancies, stock ownership, or other equity interests or patent-licensing arrangements.

Auteurs

Michele Correale (M)

Department of Cardiology, University Hospital Foggia, Italy. Electronic address: opsfco@tin.it.

Stefania Paolillo (S)

Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy.

Valentina Mercurio (V)

Department of Translational Medical Sciences, Federico II University, Naples, Italy.

Giuseppe Limongelli (G)

Heart Failure Unit, AORN dei Colli, Monaldi Hospital, Naples, Italy; Department of Translational Medical Sciences, Luigi Vanvitelli University, Naples, Italy; Institute of Cardiovascular Sciences, University College of London, London, United Kingdom.

Francesco Barillà (F)

Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, Sapienza" University of Rome, Italy.

Gaetano Ruocco (G)

Cardiovascular Diseases Unit Department of Internal Medicine, University of Siena, Siena, Italy.

Alberto Palazzuoli (A)

Cardiovascular Diseases Unit Department of Internal Medicine, University of Siena, Siena, Italy.

Domenico Scrutinio (D)

Istituti Clinici Scientifici Maugeri, IRCCS, Pavia, Italy.

Rocco Lagioia (R)

Cardiology Department, IRCCS "S. Maugeri" Cassano (BA), Bari, Italy.

Carolina Lombardi (C)

Istituto Auxologico Italiano, IRCCS, Sleep Disorders Center & Department of Cardiovascular, Neural and Metabolic Sciences. San Luca Hospital, Milan, Italy.

Laura Lupi (L)

Section of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Italy.

Damiano Magrì (D)

Department of Clinical and Molecular Medicine, University "La Sapienza", Rome, Italy.

Daniele Masarone (D)

Heart Failure Unit, AORN dei Colli, Monaldi Hospital, Naples, Italy.

Giuseppe Pacileo (G)

Heart Failure Unit, AORN dei Colli, Monaldi Hospital, Naples, Italy.

Pietro Scicchitano (P)

Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation, University of Bari "A. Moro", Bari, Italy.

Marco Matteo Ciccone (M)

Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation, University of Bari "A. Moro", Bari, Italy.

Gianfranco Parati (G)

Istituto Auxologico Italiano, IRCCS, Sleep Disorders Center & Department of Cardiovascular, Neural and Metabolic Sciences. San Luca Hospital, Milan, Italy.

Carlo G Tocchetti (CG)

Department of Translational Medical Sciences, Federico II University, Naples, Italy.

Savina Nodari (S)

Section of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH